Revenue: The sum of all revenue fields included for a company's operating activities.
Madrigal Pharmaceuticals, Inc. (MDGL) had Revenue of $212.80M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$212.80M |
$-42.28M |
|
$9.06M |
|
$203.74M |
|
$260.00M |
|
$-47.20M |
|
$4.92M |
|
$-42.28M |
|
$-42.28M |
|
$-42.28M |
|
$-42.28M |
|
$-42.28M |
|
$-42.28M |
|
$-47.20M |
|
$-46.40M |
|
22.21M |
|
22.21M |
|
$-1.90 |
|
$-1.90 |
|
| Balance Sheet Financials | |
$1.00B |
|
$1.61M |
|
$12.03M |
|
$1.02B |
|
$196.50M |
|
$118.38M |
|
$122.90M |
|
$319.40M |
|
$695.98M |
|
$691.43M |
|
$695.98M |
|
22.22M |
|
| Cash Flow Statement Financials | |
$-135.94M |
|
$211.74M |
|
$10.38M |
|
$105.02M |
|
$191.19M |
|
$86.17M |
|
$46.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.11 |
|
-- |
|
-- |
|
0.15 |
|
0.17 |
|
95.74% |
|
-22.18% |
|
-22.18% |
|
-- |
|
-19.87% |
|
-19.87% |
|
$-135.94M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.14 |
|
2.69 |
|
33.51 |
|
-6.08% |
|
-6.12% |
|
-4.16% |
|
-5.19% |
|
$31.32 |
|
$-6.12 |
|
$-6.12 |
|